Ophthalmology 360
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Photo Contest
    • Industry Council
    • Advisory Board

What are you looking for?

  • Anterior Segment
  • Cataract
  • Cornea and External Disease
  • Diabetic Macular Edema
  • Dry Eye
  • Early Onset Cataracts
  • Exclusives
  • General
  • Geographic Atrophy
  • Glaucoma
  • Industry News
  • Inherited Retinal Disease
  • IOLs
  • Neurotrophic Keratitis
  • Ocular Surface Disease
  • Oculoplastics
  • Optometry
  • Pediatrics
  • Practice Management
  • Presbyopia
  • Refractive Surgery/Vision Correction
  • Residents & Young Ophthalmologists
  • Retina
  • Retina Care 360
  • Retinopathy of Prematurity
  • Spotlight Series
  • The Interventional Glaucoma Project
  • The Ophthalmic Project
  • Trending Topics
2nd Annual Photo Contest - Enter Here!
Ophthalmology 360
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Photo Contest
    • Industry Council
    • Advisory Board
Home > Neurotrophic Keratitis > Eyelid surgery linked to nerve recovery in patients with neurotrophic keratopathy
  • Neurotrophic Keratitis

Eyelid surgery linked to nerve recovery in patients with neurotrophic keratopathy

Ophthalmology 360

Key Takeaways

  1. Comprehensive eyelid surgery was associated with recovery of corneal sensation and trophic function in patients with combined facial and trigeminal nerve palsy.
  2. All 3 patients avoided corneal neurotisation surgery after eyelid correction.

In a small case series, comprehensive eyelid surgery in patients preganglionic facial nerve palsy complicated by preganglionic trigeminal nerve palsy was associated with improvement in corneal sensation and trophic function.

The series included 3 patients with longstanding preganglionic facial nerve palsy and preganglionic trigeminal nerve palsy, with a mean disease duration of 28.3 months. All patients had eyelid abnormalities related to facial nerve palsy and underwent comprehensive eyelid surgery to address these sequelae.

At presentation, 2 of the 3 patients had complete absence of corneal sensation, and the third had reduced sensation. All cases showed absent trophic nerve function. Corneal sub-basal nerve plexus density was measured with in vivo confocal microscopy in 1 patient.

Following surgery, markers of trophic function began to improve, on average, 19 days after the procedure. Recovery of corneal sensation was observed later, with an average onset of 10 months postoperatively across the 3 patients. In the patient who underwent confocal imaging, corneal sub-basal nerve plexus nearly doubled 6 months after surgery.

Reference

Moledina M, Lim C, Dua HS, et al. Recovery of corneal sensation following eyelid surgery for neurotrophic keratopathy and preganglionic facial palsy. Br J Ophthalmol. 2026;bjo-2025-328162. doi: 10.1136/bjo-2025-328162. Epub ahead of print. PMID: 41667221.

Share

Related Content

  • Neurotrophic Keratitis

Cenegermin improves corneal healing in moderate to severe neurotrophic keratitis

  • Neurotrophic Keratitis

Shelf-stable amniotic membrane improved outcomes in early-stage neurotrophic keratopathy

  • Conference Roundup

Cryopreserved amniotic membrane significantly improves ocular surface integrity in patients with severe keratoconjunctivitis sicca and neurotrophic keratopathy

  • Conference Roundup

CAM360 with a collagen shield provides rapid epithelial healing with better tolerability and safety than when used with bandage contact lenses

  • Neurotrophic Keratitis

Early detection and targeted treatment strategies are critical for optimal outcomes in neurotrophic keratitis

  • Neurotrophic Keratitis

Amniotic membrane improves severe autoimmune-related KCS and NK outcomes

Share

Editor's Picks

  • Neurotrophic Keratitis

Topical insulin shows real-world benefit in neurotrophic keratopathy

  • Retina

GLP-1 RAs have protective effects against AMD

  • Retina

Four-month injection intervals appear safe for long-term stable nAMD

Advisory Board

Saad Ahmad, MD

Ahmad A. Aref, MD, MBA

Roomasa Channa, MD

David Chow, MD, FRCS(C)

Sally L. Baxter, MD, MSc

Neel R. Desai, MD

Nadia Haqqie, MD

Simon Fung, MD, FRCOphth

Sumit Garg, MD

Ross Lakhanpal, MD, FACS

Sanjai Jalaj, MD

Anton Kolomeyer, MD, PhD

Shan Lin, MD

Steven R. Sarkisian, Jr., MD

See All
Ophthalmology 360

Ophthalmology 360® is a dynamic digital platform dedicated to advancing the field of eye care.

Get to Know Us

  • Home
  • About Us
  • Media Partners
  • Advertising Policy
  • Our Advisory Board

Sign up for our Newsletter

Sign up for our Newsletter to get our newest articles instantly!

  • Privacy Policy
  • Advertising Policy
  • Medical Disclaimer
IHM Logo

2026 Ophthalmology 360 is a trademark of International Healthcare Media, LLC. All rights reserved

  • MedJournal360 Icon
  • RareDisease360 Icon
  • MyHero360 Icon
  • Optometry360 Icon
  • Ophtalmology360 Icon